UBS Securities picked Ambuja Cement, UltraTech, and Dalmia Bharat as top buys, citing demand recovery, lower costs, and reforms. Despite Q1 volumes missing estimates with just 3% growth, UBS expects strong EBITDA in Q2 and maintains a 7–8% FY26 growth outlook.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets